Tactile Systems Technology Inc is primarily active in the healthcare industry.

The main competitors of Tactile Systems Technology Inc in the market include companies such as Medtronic, Smith & Nephew, Hill-Rom Holdings, and Acelity.

Tactile Systems Technology Inc, commonly known as Tactile Medical, is a leading medical technology company based in Minneapolis, Minnesota. Founded in 1995, the company specializes in developing and providing at-home therapy devices and solutions for the treatment of lymphedema and chronic venous insufficiency. Tactile Medical's mission is to advance patient care by addressing unmet medical needs through innovative products and services. With its cutting-edge technology and dedication to improving patients' quality of life, Tactile Medical has become a trusted name in the medical community. Despite its relatively young age, the company has achieved significant growth and recognition, making it a promising investment option for those interested in the medical technology sector.

Tactile Systems Technology Inc has achieved several significant milestones. One notable accomplishment is its successful initial public offering in July 2016, which enabled the company to raise funds for future growth and expansion. Additionally, Tactile Systems has developed and launched innovative medical devices, including its Flexitouch system for lymphedema management. The company has received multiple awards and recognition for its contributions to the healthcare industry, such as being named to the Forbes 2017 list of America's Best Small Companies. Tactile Systems Technology Inc continues to focus on advancing patient care through its advanced medical solutions and dedication to innovation.

Tactile Systems Technology Inc is primarily present in the United States.

Tactile Systems Technology Inc is a leading medical technology company that specializes in developing and providing at-home therapy solutions. Their core values include patient-centricity, innovation, integrity, and collaboration. With a focus on improving the lives of patients with chronic diseases, Tactile Systems Technology Inc is dedicated to developing high-quality products that offer comfort and convenience. The company's corporate philosophy revolves around delivering effective and personalized healthcare solutions through a comprehensive understanding of patient needs. Tactile Systems Technology Inc consistently prioritizes patient well-being and strives to enhance their quality of life through continuous advancements in medical technology and patient care.

Analysts currently set an average price target of 30,35 USD for the Tactile Systems Technology stock (median: 34,17 USD), implying +1,4 % versus the latest price. The consensus is based on 11 analyst ratings.

Tactile Systems Technology Analyytikkojen kursstavoitteet 2026

11 analysts currently rate the Tactile Systems Technology stock: 9 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Tactile Systems Technology to generate revenue of 364,81 M USD and earnings per share of 1,10 USD.

Tactile Systems Technology Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Tactile Systems Technology share trades at 24,47 EUR (28,17 USD).

The Tactile Systems Technology share (TCMD) is listed on 3 stock exchanges, including: NASDAQ (TCMD), Frankfurt (3L3.F), München (3L3.MU).

The company Tactile Systems Technology Inc is a US-American company based in Minneapolis that specializes in the development and distribution of medical devices for the treatment of peripheral circulation disorders. The company's business model is based on a wide range of non-invasive therapy devices that are used by patients to treat circulation disorders in the lower extremities. The Tactile product portfolio includes a range of devices, from light compression stockings to advanced systems with more comprehensive functions and applications. Tactile devices have been designed to improve circulation and support the healing of chronic wounds or injuries caused by poor circulation. The therapy devices are based on a patented technological approach - a unique pneumatic system that applies pulsating pressure to the lower extremities to improve circulation and reduce edema. The devices are designed to meet a variety of patient needs and can be used both in a clinical setting and at home. In addition to its therapy devices, Tactile also offers a range of services to support patients in the effective use of the devices and improve outcomes. These include patient and medical professional training programs, support services, and data analysis tools to ensure optimal therapy. The market for peripheral circulation disorders and chronic wounds is large and growing. According to estimates from the American Heart Association, more than 8.5 million people in the United States alone suffer from circulation disorders in the lower extremities, and this number is expected to continue rising due to factors such as increasing age and lifestyle diseases like diabetes. Tactile has managed to establish itself as a market leader in this segment by providing innovative products and services tailored to the needs of patients and medical professionals. The company has built a strong brand and made its products popular among doctors and clinics in the US. It also has a strong presence in the international market and has successfully expanded into new regions. Overall, Tactile offers its customers an integrated system of therapy devices and services aimed at improving the treatment of circulation disorders and maximizing patient outcomes. With its proven business model, strong brand presence, and commitment to product innovation and quality, Tactile is well positioned to continue growing successfully and increase its market share.

odotettu liikevaihto Tactile Systems Technology on 364,81 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Tactile Systems Technology on 25,36 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Tactile Systems Technology:n hinta-voitto-suhde (P/E) on tällä hetkellä 25,60. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Tactile Systems Technology-osakkeen arvostusta.

Tactile Systems Technology:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,78. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Tactile Systems Technology-osakkeen arvostuskennuslukuna.

Tactile Systems Technology:n Eulpool-laatuscore on 6/10.

Tactile Systems Technology:n ISIN on US87357P1003. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Tactile Systems Technology:n WKN on A2APEV. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Tactile Systems Technology:n ticker on TCMD. Tämä pörssinoteeraus käytetään Tactile Systems Technology-osakkeiden kauppaan pörssissä.

Tactile Systems Technology maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Tactile Systems Technology kuuluu sektoriin 'Terveydenhuolto'.

Tactile Systems Technology:n osingot jaetaan valuutassa USD.